Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Cardiac amyloidosis].
Poullot E, Oghina S, Kalsoum S, Damy T. Poullot E, et al. Among authors: oghina s. Ann Pathol. 2021 Feb;41(1):25-37. doi: 10.1016/j.annpat.2020.11.010. Epub 2021 Jan 6. Ann Pathol. 2021. PMID: 33422349 French.
Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment.
Gounot R, Le Bras F, Dupuis J, Oghina S, Bodez D, Roulin L, Maarek A, Ladaique A, Beldi-Ferchiou A, Poullot E, Molinier-Frenkel V, Haioun C, Damy T, Belhadj K, Lemonnier F. Gounot R, et al. Among authors: oghina s. Leuk Lymphoma. 2021 Apr;62(4):979-983. doi: 10.1080/10428194.2020.1850717. Epub 2020 Nov 29. Leuk Lymphoma. 2021. PMID: 33251891 No abstract available.
Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement.
Bézard M, Oghina S, Vitiello D, Kharoubi M, Kordeli E, Galat A, Zaroui A, Guendouz S, Gilles F, Shourick J, Hamon D, Audard V, Teiger E, Poullot E, Molinier-Frenkel V, Lemonnier F, Agbulut O, Le Bras F, Damy T. Bézard M, et al. Among authors: oghina s. PLoS One. 2021 Sep 15;16(9):e0257189. doi: 10.1371/journal.pone.0257189. eCollection 2021. PLoS One. 2021. PMID: 34525116 Free PMC article.
History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis.
Kharoubi M, Bézard M, Galat A, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Funalot B, Moktefi A, Lefaucheur JP, Abulizi M, Deux JF, Lemonnier F, Guendouz S, Chalard C, Zaroui A, Audard V, Bequignon E, Bodez D, Itti E, Hittinger L, Audureau E, Teiger E, Oghina S, Damy T. Kharoubi M, et al. Among authors: oghina s. ESC Heart Fail. 2021 Dec;8(6):5501-5512. doi: 10.1002/ehf2.13652. Epub 2021 Oct 29. ESC Heart Fail. 2021. PMID: 34714605 Free PMC article.
Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis.
Bonnefous L, Kharoubi M, Bézard M, Oghina S, Le Bras F, Poullot E, Molinier-Frenkel V, Fanen P, Deux JF, Audard V, Itti E, Damy T, Audureau E. Bonnefous L, et al. Among authors: oghina s. J Am Coll Cardiol. 2021 Nov 30;78(22):2177-2192. doi: 10.1016/j.jacc.2021.09.858. J Am Coll Cardiol. 2021. PMID: 34823661 Free article.
Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival.
Kharoubi M, Bodez D, Bézard M, Zaroui A, Galat A, Guendouz S, Gendre T, Hittinger L, Attias D, Mohty D, Bergoend E, Itti E, Lebras F, Hamon D, Poullot E, Molinier-Frenkel V, Lellouche N, Deux JF, Funalot B, Fannen P, Oghina S, Arrouasse R, Lecorvoisier P, Souvannanorath S, Amiot A, Teiger E, Bougouin W, Damy T. Kharoubi M, et al. Among authors: oghina s. Amyloid. 2022 Jun;29(2):79-91. doi: 10.1080/13506129.2021.2013193. Epub 2022 Feb 4. Amyloid. 2022. PMID: 35114877 Free article.
Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value.
Malka N, Abulizi M, Kharoubi M, Oghina S, Galat A, Le Bras F, Moktefi A, Guendouz S, Molinier-Frenkel V, Fanen P, Funalot B, Lefaucheur JP, Blanc-Durand P, Deux JF, Audard V, Bodez D, Itti E, Damy T. Malka N, et al. Among authors: oghina s. Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2396-2406. doi: 10.1007/s00259-020-04753-7. Epub 2020 Mar 10. Eur J Nucl Med Mol Imaging. 2020. PMID: 32157431
Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis.
Bézard M, Kharoubi M, Galat A, Poullot E, Guendouz S, Fanen P, Funalot B, Moktefi A, Lefaucheur JP, Abulizi M, Deux JF, Gendre T, Audard V, El Karoui K, Canoui-Poitrine F, Zaroui A, Itti E, Teiger E, Planté-Bordeneuve V, Oghina S, Damy T. Bézard M, et al. Among authors: oghina s. Eur J Heart Fail. 2021 Feb;23(2):264-274. doi: 10.1002/ejhf.2028. Epub 2020 Nov 9. Eur J Heart Fail. 2021. PMID: 33094885 Free article.
Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis.
Kharoubi M, Roche F, Bézard M, Hupin D, Silva S, Oghina S, Chalard C, Zaroui A, Galat A, Guendouz S, Canoui-Poitrine F, Hittinger L, Teiger E, Lefaucheur JP, Damy T. Kharoubi M, et al. Among authors: oghina s. ESC Heart Fail. 2021 Apr;8(2):1656-1665. doi: 10.1002/ehf2.13131. Epub 2020 Dec 22. ESC Heart Fail. 2021. PMID: 33354901 Free PMC article.
40 results